Xinghui Zhao
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification.
Journal: Translational lung cancer research
Published: March 15, 2021
Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients.
Journal: Annals of translational medicine
Published: February 08, 2021
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients.
Journal: Cancer cell international
Published: July 04, 2020
Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
Journal: BMC cancer
Published: September 19, 2019
Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
Journal: Thoracic cancer
Published: February 02, 2019
Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis.
Journal: Thoracic cancer
Published: October 29, 2018
CHIP/Stub1 interacts with eIF5A and mediates its degradation.
Journal: Cellular signalling
Published: September 24, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026